Market Forecast By Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals, Specialty Clinics, Others) And Competitive Landscape
Product Code: ETC362523 | Publication Date: Aug 2022 | Updated Date: May 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | Mexico Cardiovascular Devices Market |
Forecast period | 2024-2030 |
CAGR | 6.6% |
Growing Sector | Diagnostic and Monitoring devices |
The Mexico Cardiovascular Devices Market report thoroughly covers the market by Device Type, End-User, and Application. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Mexico Cardiovascular Devices Market is expected to see significant growth in the coming years due to many reasons. The market is also facing some challenges which can lower the growth of the market and can increase the death in the country. The government has taken initiatives and even collaborated with World health organizations to support the growth of the market.
According to 6Wresearch, the Mexico Cardiovascular Devices Market size is expected to reach a CAGR of 6.6% during the forecast period from 2024 - 2030. Cardiovascular diseases (CVDs) are one of the leading causes of death in Mexico. With the ageing population and adopting unhealthy lifestyles, the prevalence of CVDs is expected to rise further, driving the demand for cardiovascular devices. The government has increased expenditure in the healthcare industry. This has led to increased investments in medical devices, including cardiovascular devices. Hence, this has driven the CVD market in Mexico. The market for cardiovascular devices in Mexico is also driven by advancements in technology. As new and more advanced devices are introduced, patients and healthcare providers are more likely to opt for them, leading to a higher demand. The government’s policies have created a favourable environment for cardiovascular device manufacturers to operate in Mexico.
Despite the high prevalence of CVDs in Mexico, there is still a lack of awareness about these conditions and the available treatment options. This lack of awareness can limit the demand for cardiovascular devices. The high cost of cardiovascular devices makes them inaccessible to low-income individuals. This high cost of devices can limit the market's growth potential and hinder patients from receiving necessary treatments. The regulatory framework for medical devices in Mexico is still developing and can be complex for manufacturers to navigate. The lengthy and stringent approval process may delay device launches in the country, limiting the Mexico Cardiovascular Devices Market Growth.
The cardiovascular devices industry in Mexico has seen significant growth, driven by rising incidences of cardiovascular diseases and advancements in medical technology. Leading players in this market include both international giants and notable domestic companies. Among the prominent international companies are Medtronic, Abbott Laboratories, and Boston Scientific, which have established a strong presence in the Mexican market through innovative products and strategic partnerships. Additionally, domestic companies like Bio-Mac and Smiths Medical have earned recognition for their contributions to the industry, providing tailored solutions that cater to the specific needs of the Mexican population.
To further support the growth and improve the overall healthcare system, the Mexican government has implemented several initiatives. One such initiative is the National Health Program (NHP), launched by the Mexican Ministry of Health in 2007. The program aims to improve healthcare access and quality for the entire population, with a focus on vulnerable groups such as low-income families and individuals living in rural areas. The Mexican government has also implemented the National Strategy for Prevention and Control of Cardiovascular Diseases (ENPRECVAD), which focuses on promoting healthy lifestyles and preventing risk factors for cardiovascular diseases. The government has also invested in the development of healthcare infrastructure in the country, including the construction of new hospitals and clinics. Moreover, the Mexican government has collaborated with international organizations such as the World Health Organization (WHO) to improve healthcare standards and access in the country.
The Mexico cardiovascular devices industry is poised for substantial growth in the coming years. Key drivers of this expansion include a rising prevalence of cardiovascular diseases, advancements in medical technology, and an increasing geriatric population. Innovations in minimally invasive procedures and the integration of artificial intelligence in diagnostic and monitoring devices are expected to play pivotal roles in shaping the market landscape. Moreover, government initiatives aimed at improving healthcare infrastructure and access are likely to support market growth. With continuous research and development, the market is set to witness the introduction of more effective and efficient cardiovascular solutions, potentially reducing the burden of heart-related ailments in Mexico.
According to Ravi Bhandari, Research Manager, 6Wresearch, the Diagnostic And Monitoring Devices segment dominates the Mexico Cardiovascular Devices Market Share due to the increasing prevalence of cardiovascular diseases in the country. These devices play a crucial role in detecting and monitoring various cardiovascular conditions such as heart attacks, arrhythmias, and heart failure.
Based on the Application, the coronary artery disease (CAD) segment holds the leading position in the market. The high prevalence of CAD has led to an increased demand for cardiovascular devices such as stents, catheters, and heart valves. According to a report by the World Health Organization (WHO), CVDs account for 28% of all deaths in Mexico.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Cardiovascular Devices Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Cardiovascular Devices Market Revenues & Volume, 2020 & 2030F |
3.3 Mexico Cardiovascular Devices Market - Industry Life Cycle |
3.4 Mexico Cardiovascular Devices Market - Porter's Five Forces |
3.5 Mexico Cardiovascular Devices Market Revenues & Volume Share, By Device Type, 2020 & 2030F |
3.6 Mexico Cardiovascular Devices Market Revenues & Volume Share, By Application, 2020 & 2030F |
3.7 Mexico Cardiovascular Devices Market Revenues & Volume Share, By End User, 2020 & 2030F |
4 Mexico Cardiovascular Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mexico Cardiovascular Devices Market Trends |
6 Mexico Cardiovascular Devices Market Segmentations |
6.1 Mexico Cardiovascular Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Cardiovascular Devices Market Revenues & Volume, By Diagnostic and Monitoring Devices, 2020-2030F |
6.1.3 Mexico Cardiovascular Devices Market Revenues & Volume, By Therapeutic and Surgical Devices, 2020-2030F |
6.2 Mexico Cardiovascular Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico Cardiovascular Devices Market Revenues & Volume, By Coronary Artery Disease (CAD), 2020-2030F |
6.2.3 Mexico Cardiovascular Devices Market Revenues & Volume, By Cardiac Arrhythmia, 2020-2030F |
6.2.4 Mexico Cardiovascular Devices Market Revenues & Volume, By Heart Failure, 2020-2030F |
6.2.5 Mexico Cardiovascular Devices Market Revenues & Volume, By Others, 2020-2030F |
6.3 Mexico Cardiovascular Devices Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Cardiovascular Devices Market Revenues & Volume, By Hospitals, 2020-2030F |
6.3.3 Mexico Cardiovascular Devices Market Revenues & Volume, By Specialty Clinics, 2020-2030F |
6.3.4 Mexico Cardiovascular Devices Market Revenues & Volume, By Others, 2020-2030F |
7 Mexico Cardiovascular Devices Market Import-Export Trade Statistics |
7.1 Mexico Cardiovascular Devices Market Export to Major Countries |
7.2 Mexico Cardiovascular Devices Market Imports from Major Countries |
8 Mexico Cardiovascular Devices Market Key Performance Indicators |
9 Mexico Cardiovascular Devices Market - Opportunity Assessment |
9.1 Mexico Cardiovascular Devices Market Opportunity Assessment, By Device Type, 2020 & 2030F |
9.2 Mexico Cardiovascular Devices Market Opportunity Assessment, By Application, 2020 & 2030F |
9.3 Mexico Cardiovascular Devices Market Opportunity Assessment, By End User, 2020 & 2030F |
10 Mexico Cardiovascular Devices Market - Competitive Landscape |
10.1 Mexico Cardiovascular Devices Market Revenue Share, By Companies, 2023 |
10.2 Mexico Cardiovascular Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |